Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

NCT07326631 is registered in ClinicalTrials.gov with College of Physicians and Surgeons Pakistan as lead sponsor.

NCT NCT07326631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07326631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure
Lead sponsor
College of Physicians and Surgeons Pakistan
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
July 1, 2026
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease (dkd), heart failure